Jérémy Magalon received his PharmD at the University of Aix-Marseille in 2013 after completing his internship in medical biology with a specialization in cell therapy. He holds a university degree in regenerative medicine and a master's degree in tissue, cell and gene biology. During his internship, he mainly works on autologous PRP therapy and his other areas of expertise are autologous stromal vascular fraction derived from adipose tissue and adipose tissue graft. In 2014, he became a hospital practitioner at the Necker Hospital (Paris) in the biotherapy department where he was involved in clinical trials using gene therapy to cure patients with severe hemoglobinopathy. He graduated as a doctor of science in 2018 entitled "Development of an Innovative Therapy Drug Using the Stromal Vascular Fraction of Autologous Adipose Tissue in Systemic Sclerosis: From Biological Characterization to Identification of Potential Biomarkers of Efficacy" . He is currently Senior Lecturer and Hospital Practitioner at the University of Aix-Marseille (Faculty of Pharmacy) and at the University Hospital of La Conception (Department of Cell Therapy).
Since October 2017, he coordinates the platelet - rich plasma injection activity of the University Hospital of Marseille, where PRP is used in various medical fields. He is the author of more than 50 articles and 2 chapters of books in Regenerative Medicine, and has been a speaker at more than 30 national and international conferences and courses.
